Literature DB >> 21841280

Improving diabetic retinopathy screening through a statewide telemedicine program at a large federally qualified health center.

J N Olayiwola1, D M Sobieraj, K Kulowski, D St Hilaire, J J Huang.   

Abstract

BACKGROUND: Diabetic retinopathy (DR) is the leading cause of acquired blindness in U.S. adults. Early detection prevents progression. Screening rates are only 10% in medically underserved populations.
METHODS: A statewide telemedicine-based program within primary care centers was implemented to improve DR screening, detection and referrals for underserved patients. STUDY
DESIGN: Retrospective, descriptive study.
RESULTS: A total of 568 adults were screened during a comprehensive nurse visit from July 2009-June 2010 and had complete data available. Nearly 60% were minorities and 24% were uninsured. A total of 145 cases of DR were identified. The majority were recommended to return in one year for follow-up, while 75 were referred to a specialist.
CONCLUSIONS: Telemedicine using digital imaging technology in the primary care office is a strategy that can be used to screen underserved and at-risk patients for DR, increase compliance with screening, and streamline specialist referrals.

Entities:  

Mesh:

Year:  2011        PMID: 21841280     DOI: 10.1353/hpu.2011.0066

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  14 in total

1.  Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine.

Authors:  Cynthia Owsley; Gerald McGwin; David J Lee; Byron L Lam; David S Friedman; Emily W Gower; Julia A Haller; Lisa A Hark; Jinan Saaddine
Journal:  JAMA Ophthalmol       Date:  2015-02       Impact factor: 7.389

Review 2.  Can Commercially Available Handheld Retinal Cameras Effectively Screen Diabetic Retinopathy?

Authors:  Jorge Cuadros; George Bresnick
Journal:  J Diabetes Sci Technol       Date:  2016-12-18

3.  Long-term Comparative Effectiveness of Telemedicine in Providing Diabetic Retinopathy Screening Examinations: A Randomized Clinical Trial.

Authors:  Steven L Mansberger; Christina Sheppler; Gordon Barker; Stuart K Gardiner; Shaban Demirel; Kathleen Wooten; Thomas M Becker
Journal:  JAMA Ophthalmol       Date:  2015-05       Impact factor: 7.389

Review 4.  Operational Components of Telemedicine Programs for Diabetic Retinopathy.

Authors:  Mark B Horton; Paolo S Silva; Jerry D Cavallerano; Lloyd Paul Aiello
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

5.  Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network.

Authors:  Pooja D Jani; Lauren Forbes; Arkopal Choudhury; John S Preisser; Anthony J Viera; Seema Garg
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

6.  Geographic Information Systems Mapping of Diabetic Retinopathy in an Ocular Telemedicine Network.

Authors:  Pooja D Jani; Lauren Forbes; Philip McDaniel; Anthony Viera; Seema Garg
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

Review 7.  Presence and Risk Factors for Glaucoma in Patients with Diabetes.

Authors:  Brian J Song; Lloyd Paul Aiello; Louis R Pasquale
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

8.  Diabetic retinopathy screening with pharmacy-based teleophthalmology in a semiurban setting: a cost-effectiveness analysis.

Authors:  Andrea C Coronado; Gregory S Zaric; Janet Martin; Monali Malvankar-Mehta; Francie F Si; William G Hodge
Journal:  CMAJ Open       Date:  2016-03-08

9.  First Clinical Application of Low-Cost OCT.

Authors:  Ge Song; Kengyeh K Chu; Sanghoon Kim; Michael Crose; Brian Cox; Evan T Jelly; J Niklas Ulrich; Adam Wax
Journal:  Transl Vis Sci Technol       Date:  2019-06-28       Impact factor: 3.283

10.  Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography.

Authors:  Marcus Kernt; Indrawati Hadi; Florian Pinter; Florian Seidensticker; Christoph Hirneiss; Christos Haritoglou; Anselm Kampik; Michael W Ulbig; Aljoscha S Neubauer
Journal:  Diabetes Care       Date:  2012-08-21       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.